Task: Answer the following question about the molecule with SMILES CCN(CC)C(=O)CNC(=O)c1cc(OC)c(OC)c(OC)c1.
Request: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Result: Phase 1 Clinical Trials
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CCN(CC)C(=O)CNC(=O)c1cc(OC)c(OC)c(OC)c1
CCN(CC)C(=O)CNC(=O)c1cc(OC)c(OC)c(OC)c1
N-[2-(diethylamino)-2-oxoethyl]-3,4,5-trimethoxybenzamide
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.